A nonsynonymous variant in PLCG2 is associated with reduced risk of ADD, DLB, and frontotemporal dementia, suggesting a broad influence on the mechanisms of neurodegeneration, most likely neuroinflammation [33, 74]. This evidence concerns the gene PLCG2 and Lewy body dementia.